Zebrafish an experimental model of Huntington's disease: molecular aspects, therapeutic targets and current challenges

被引:22
作者
Kumar, Vishal [1 ]
Singh, Charan [2 ,3 ]
Singh, Arti [1 ]
机构
[1] ISF Coll Pharm, Dept Pharmacol, Moga 142001, Punjab, India
[2] ISF Coll Pharm, Dept Pharmaceut, Moga 142001, Punjab, India
[3] IK Gujral Punjab Tech Univ, Jalandhar 144603, Punjab, India
关键词
Huntington disease; Neurodegeneration; HD mechanisms; Therapeutic targets; Therapeutic approaches; Zebrafish; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; TRKB RECEPTOR; MOUSE MODEL; IN-VIVO; PROTEIN; AGGREGATION; EXPRESSION; SURVIVAL; ACID;
D O I
10.1007/s11033-021-06787-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington disease (HD) is a lethal autosomal dominant neurodegenerative disease whose exact causative mechanism is still unknown. It can transform from one generation to another generation. The CAG triplet expansion on polyglutamine (PolyQ) tract on Huntingtin protein primarily contributes in HD pathogenesis. Apart from this some another molecular mechanisms are also involved in HD pathology such as loss of Brain derived neurotrophic factor in medium spiny neurons, mitochondrial dysfunction, and alterations in synaptic plasticity are briefly discussed in this review. However, several chemicals (3-nitropropionic acid, and Quinolinic acid) and genetic (mHTT-Delta N17-97Q over expression) experimental models are used to explore the exact pathogenic mechanism and finding of new drug targets for the development of novel therapeutic approaches. The zebrafish (Danio rerio) is widely used in in-vivo screening of several central nervous system (CNS) diseases such as HD, Alzheimer's disease (AD), Parkinson's disease (PD), and in memory deficits. Thus, this makes zebrafish as an excellent animal model for the development of new therapeutic strategies against various CNS disorders. We had reviewed several publications utilizing zebrafish and rodents to explore the disease pathology. Studies suggested that zebrafish genes and their human homologues have conserved functions. Zebrafish advantages and their characteristics over the other experimental animals make it an excellent tool for the disease study. This review explains the possible pathogenic mechanism of HD and also discusses about possible treatment therapies, apart from this we also discussed about possible potential therapeutic targets which will helps in designing of novel therapeutic approaches to overcome the disease progression. Graphic abstract Diagrammatic depiction shows prevention of HD pathogenesis through attenuation of various biochemical alterations.
引用
收藏
页码:8181 / 8194
页数:14
相关论文
共 100 条
[1]   D mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington's disease [J].
Abd-Elrahman, Khaled S. ;
Hamilton, Alison ;
Hutchinson, Shaunessy R. ;
Liu, Fang ;
Russell, Ryan C. ;
Ferguson, Stephen S. G. .
SCIENCE SIGNALING, 2017, 10 (510)
[2]   A cell-based screen for drugs to treat Huntington's disease [J].
Aiken, CT ;
Tobin, AJ ;
Schweitzer, ES .
NEUROBIOLOGY OF DISEASE, 2004, 16 (03) :546-555
[3]   Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction [J].
Anastasia, Agustin ;
Deinhardt, Katrin ;
Chao, Moses V. ;
Will, Nathan E. ;
Irmady, Krithi ;
Lee, Francis S. ;
Hempstead, Barbara L. ;
Bracken, Clay .
NATURE COMMUNICATIONS, 2013, 4
[4]   Targeting glutamate mediated excitotoxicity in huntington's disease: Neural progenitors and partial glutamate antagonist - Memantine [J].
Anitha, M. ;
Nandhu, M. S. ;
Anju, T. R. ;
Jes, P. ;
Paulose, C. S. .
MEDICAL HYPOTHESES, 2011, 76 (01) :138-140
[5]   Osmolytes dynamically regulate mutant Huntingtin aggregation and CREB function in Huntington's disease cell models [J].
Aravindan, Shreyaas ;
Chen, Samantha ;
Choudhry, Hannaan ;
Molfetta, Celine ;
Chen, Kuang Yu ;
Liu, Alice Y. C. .
SCIENTIFIC REPORTS, 2020, 10 (01)
[6]   In vivo aspects of protein folding and quality control [J].
Balchin, David ;
Hayer-Hartl, Manajit ;
Hartl, F. Ulrich .
SCIENCE, 2016, 353 (6294)
[7]   Mitochondrial Dysfunction in Neurodegenerative Diseases [J].
Johri, Ashu ;
Beal, M. Flint .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (03) :619-630
[8]   Zebrafish Tg(hb9:MTS-Kaede): a new in vivo tool for studying the axonal movement of mitochondria [J].
Bergamin, Giorgia ;
Cieri, Domenico ;
Vazza, Giovanni ;
Argenton, Francesco ;
Mostacciuolo, Maria Luisa .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (06) :1247-1255
[9]   GABAergic Dysfunction in Essential Tremor: An 11C-Flumazenil PET Study [J].
Boecker, Henning ;
Weindl, Adolf ;
Brooks, David J. ;
Ceballos-Baumann, Andres O. ;
Liedtke, Christoph ;
Miederer, Matthias ;
Sprenger, Till ;
Wagner, Klaus J. ;
Miederer, Isabelle .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (07) :1030-1035
[10]   Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity [J].
Branco-Santos, Joana ;
Herrera, Federico ;
Pocas, Goncalo M. ;
Pires-Afonso, Yolanda ;
Giorgini, Flaviano ;
Domingos, Pedro M. ;
Outeiro, Tiago F. .
HUMAN MOLECULAR GENETICS, 2017, 26 (19) :3763-3775